Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities

07, Jun 2026

2
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Insights from UK Biobank

06, Jun 2026

3
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction
Genetics
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction

05, Jun 2026

4
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries
Genetics
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries

04, Jun 2026

5
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort

03, Jun 2026

Categories:
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis

27, Aug 2025

Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology
Genetics
Multiple Sclerosis: CHIT1 and SERPINA3 as Candidate CSF Biomarkers of Progressive Biology

28, Aug 2025